SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Vasogen-- VAS on TSE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tnsaf who wrote (276)12/15/2004 11:23:56 AM
From: caly  Read Replies (1) of 377
 
Compliments of a Yahoo poster...

Comment from AG Edwards report last week on cardiovascular co's.

Vasogen (VSGN): Dr. Guillermo Torre-Amione reinforced our confidence in Celacade by
emphasizing the treatment’s benign safety profile and its compatibility with other treatments,
while alleviating potential concerns over administration. One of the concerns dogging Celacade
as an anti-inflammatory treatment has been its unusual method of administration. (Please see the
background description below.) While Dr. Torre-Amione admitted that physician education will
be critical to the treatment’s success, he also argued that the fact that the treatment is administered
only once per month makes it quite attractive. While this does involve drawing blood and
receiving an injection, this process is actually easier than adding another pill onto a daily
medication roster that may already contain 4-7 drugs for heart-failure patients. As evidence of the
procedure’s acceptance, Dr. Torre-Amione pointed out that not one of the patients in the Celacade
trials dropped out.

More importantly, Celacade’s safety profile is very strong and the treatment has been
compatible with other medications. These two points are critical, as high-blood pressure
treatments such as ACE inhibitors and beta blockers tend to have noticeable side effects.
Furthermore, heart disease patients are often on multiple medications, and there is always the risk
of unfavorable interaction amongst them. From this perspective, Celacade appears to be an ideal
add-on.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News